AIM
AIM ImmunoTech Inc.$0.16-0.01 (-3.29%)Prev Close$0.16·MCap$6.2M·P/E—·Vol298.6K·Yield—
▲
Buys (12M)
6
$23.6K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$23.6K
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at AIM ImmunoTech Inc. (AIM) has been exclusively buying, with 6 insider purchases totaling $23.6K and 0 insider sales totaling $0.00. The most recent insider transaction was by Equels Thomas K (director, officer: CEO & President), who purchased $5.1K worth of shares on Oct 26, 2026. AIM ImmunoTech Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.2M.
AIM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 31,675 | $0.16 | $5.1K | 189,747 |
| Oct 23, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 31,250 | $0.16 | $5.1K | 158,072 |
| Sep 18, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 24,000 | $0.21 | $5.0K0.7% OS | 126,822 |
| Sep 17, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 11,000 | $0.21 | $2.3K | 102,822 |
| Sep 16, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 22,000 | $0.22 | $4.9K0.6% OS | 91,822+32% |
| Sep 15, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 5,900 | $0.22 | $1.3K | 69,822 |
| Jun 12, 2025 | Equels Thomas K | CEO & President | Buy | 210 | $8.19 | $1.7K | 0 |
| Apr 21, 2025 | Equels Thomas K | CEO & President | Buy | 1,968,504 | $0.03 | $50.0K57.8% OS | 0 |
| Apr 21, 2025 | MITCHELL WILLIAM M | Director | Buy | 196,851 | $0.03 | $5.0K5.8% OS | 0 |
| Apr 4, 2025 | Equels Thomas K | CEO & President | Buy | 41,000 | $0.06 | $2.6K1.2% OS | 0 |
| Apr 4, 2025 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 500 | $0.09 | $43.50 | 0 |
| Mar 5, 2025 | Equels Thomas K | CEO & President | Buy | 50,000 | $0.13 | $6.7K1.5% OS | 0 |
| Mar 4, 2025 | Equels Thomas K | CEO & President | Buy | 127,334 | $0.12 | $15.1K3.7% OS | 0 |
| Dec 19, 2024 | MITCHELL WILLIAM M | Director | Sell | 4,580 | $0.19 | $883.94 | 0 |
| Dec 18, 2024 | Equels Thomas K | CEO & President | Buy | 22,727 | $0.21 | $4.7K0.7% OS | 0 |
| Dec 2, 2024 | APPELROUTH STEWART | Director | Buy | 11,112 | $0.21 | $2.4K | 0 |
| Nov 21, 2024 | Equels Thomas K | CEO & President | Buy | 20,000 | $0.21 | $4.2K0.6% OS | 0 |
| Nov 20, 2024 | APPELROUTH STEWART | Director | Buy | 81,953 | $0.19 | $15.8K2.4% OS | 0 |
| Nov 20, 2024 | Equels Thomas K | CEO & President | Buy | 145,110 | $0.19 | $27.9K4.3% OS | 0 |
| Sep 16, 2024 | Equels Thomas K | CEO & President | Buy | 5,000 | $0.30 | $1.5K | 0 |
| Sep 13, 2024 | Equels Thomas K | CEO & President | Buy | 20,000 | $0.31 | $6.2K0.6% OS | 0 |
| May 6, 2024 | Equels Thomas K | CEO & President | Buy | 61,729 | $0.40 | $25.0K1.8% OS | 0 |
| May 6, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 30,865 | $0.40 | $12.5K0.9% OS | 0 |
| Mar 21, 2024 | BRYAN NANCY | Director | Buy | 38,462 | $0.39 | $15.0K1.1% OS | 0 |
| Mar 15, 2024 | APPELROUTH STEWART | Director | Buy | 90,910 | $0.33 | $30.0K2.7% OS | 0 |
| Mar 15, 2024 | Equels Thomas K | CEO & President | Buy | 75,758 | $0.33 | $25.0K2.2% OS | 0 |
| Mar 15, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 37,879 | $0.33 | $12.5K1.1% OS | 0 |
| Nov 27, 2023 | Equels Thomas K | CEO & President | Buy | 33,861 | $0.44 | $15.0K1.0% OS | 0 |
| Sep 29, 2023 | Equels Thomas K | CEO & President | Buy | 22,676 | $0.44 | $10.0K0.7% OS | 0 |
| Aug 25, 2023 | Equels Thomas K | CEO & President | Buy | 8,222 | $0.67 | $5.5K | 0 |
| Aug 24, 2023 | Equels Thomas K | CEO & President | Buy | 14,993 | $0.67 | $10.0K | 0 |
| Jul 17, 2023 | Equels Thomas K | CEO & President | Buy | 16,950 | $0.59 | $10.0K | 0 |
| Jan 3, 2023 | APPELROUTH STEWART | Director | Buy | 80,646 | $0.31 | $25.0K2.4% OS | 0 |
| Jan 3, 2023 | Equels Thomas K | CEO & President | Buy | 161,291 | $0.31 | $50.0K4.7% OS | 0 |
| Jul 16, 2021 | EQUELS THOMAS K. | CEO & President | Buy | 15,625 | $1.92 | $30.0K | 0 |
| Feb 25, 2021 | APPELROUTH STEWART | Director | Buy | 10,638 | $2.35 | $25.0K | 0 |
| Feb 24, 2021 | EQUELS THOMAS K. | CEO & President | Buy | 11,062 | $2.26 | $25.0K | 0 |
AIM Insider Buying Activity
The following table shows recent insider purchases of AIM ImmunoTech Inc. (AIM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 31,675 | $0.16 | $5.1K | 189,747 |
| Oct 23, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 31,250 | $0.16 | $5.1K | 158,072 |
| Sep 18, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 24,000 | $0.21 | $5.0K0.7% OS | 126,822 |
| Sep 17, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 11,000 | $0.21 | $2.3K | 102,822 |
| Sep 16, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 22,000 | $0.22 | $4.9K0.6% OS | 91,822+32% |
| Sep 15, 2026 | Equels Thomas K | director, officer: CEO & President | Buy | 5,900 | $0.22 | $1.3K | 69,822 |
| Jun 12, 2025 | Equels Thomas K | CEO & President | Buy | 210 | $8.19 | $1.7K | 0 |
| Apr 21, 2025 | Equels Thomas K | CEO & President | Buy | 1,968,504 | $0.03 | $50.0K57.8% OS | 0 |
| Apr 21, 2025 | MITCHELL WILLIAM M | Director | Buy | 196,851 | $0.03 | $5.0K5.8% OS | 0 |
| Apr 4, 2025 | Equels Thomas K | CEO & President | Buy | 41,000 | $0.06 | $2.6K1.2% OS | 0 |
| Apr 4, 2025 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 500 | $0.09 | $43.50 | 0 |
| Mar 5, 2025 | Equels Thomas K | CEO & President | Buy | 50,000 | $0.13 | $6.7K1.5% OS | 0 |
| Mar 4, 2025 | Equels Thomas K | CEO & President | Buy | 127,334 | $0.12 | $15.1K3.7% OS | 0 |
| Dec 18, 2024 | Equels Thomas K | CEO & President | Buy | 22,727 | $0.21 | $4.7K0.7% OS | 0 |
| Dec 2, 2024 | APPELROUTH STEWART | Director | Buy | 11,112 | $0.21 | $2.4K | 0 |
| Nov 21, 2024 | Equels Thomas K | CEO & President | Buy | 20,000 | $0.21 | $4.2K0.6% OS | 0 |
| Nov 20, 2024 | APPELROUTH STEWART | Director | Buy | 81,953 | $0.19 | $15.8K2.4% OS | 0 |
| Nov 20, 2024 | Equels Thomas K | CEO & President | Buy | 145,110 | $0.19 | $27.9K4.3% OS | 0 |
| Sep 16, 2024 | Equels Thomas K | CEO & President | Buy | 5,000 | $0.30 | $1.5K | 0 |
| Sep 13, 2024 | Equels Thomas K | CEO & President | Buy | 20,000 | $0.31 | $6.2K0.6% OS | 0 |
| May 6, 2024 | Equels Thomas K | CEO & President | Buy | 61,729 | $0.40 | $25.0K1.8% OS | 0 |
| May 6, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 30,865 | $0.40 | $12.5K0.9% OS | 0 |
| Mar 21, 2024 | BRYAN NANCY | Director | Buy | 38,462 | $0.39 | $15.0K1.1% OS | 0 |
| Mar 15, 2024 | APPELROUTH STEWART | Director | Buy | 90,910 | $0.33 | $30.0K2.7% OS | 0 |
| Mar 15, 2024 | Equels Thomas K | CEO & President | Buy | 75,758 | $0.33 | $25.0K2.2% OS | 0 |
| Mar 15, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 37,879 | $0.33 | $12.5K1.1% OS | 0 |
| Nov 27, 2023 | Equels Thomas K | CEO & President | Buy | 33,861 | $0.44 | $15.0K1.0% OS | 0 |
| Sep 29, 2023 | Equels Thomas K | CEO & President | Buy | 22,676 | $0.44 | $10.0K0.7% OS | 0 |
| Aug 25, 2023 | Equels Thomas K | CEO & President | Buy | 8,222 | $0.67 | $5.5K | 0 |
| Aug 24, 2023 | Equels Thomas K | CEO & President | Buy | 14,993 | $0.67 | $10.0K | 0 |
| Jul 17, 2023 | Equels Thomas K | CEO & President | Buy | 16,950 | $0.59 | $10.0K | 0 |
| Jan 3, 2023 | APPELROUTH STEWART | Director | Buy | 80,646 | $0.31 | $25.0K2.4% OS | 0 |
| Jan 3, 2023 | Equels Thomas K | CEO & President | Buy | 161,291 | $0.31 | $50.0K4.7% OS | 0 |
| Jul 16, 2021 | EQUELS THOMAS K. | CEO & President | Buy | 15,625 | $1.92 | $30.0K | 0 |
| Feb 25, 2021 | APPELROUTH STEWART | Director | Buy | 10,638 | $2.35 | $25.0K | 0 |
| Feb 24, 2021 | EQUELS THOMAS K. | CEO & President | Buy | 11,062 | $2.26 | $25.0K | 0 |
AIM Insider Selling Activity
The following table shows recent insider sales of AIM ImmunoTech Inc. (AIM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | MITCHELL WILLIAM M | Director | Sell | 4,580 | $0.19 | $883.94 | 0 |
AIM Insiders
Similar Stocks to AIM
MRNA
Moderna, Inc.
$219.87-1.26%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$923.97+12.96%
$83.15B
RVMD
Revolution Medicines, Inc.
$190.97+0.34%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$164.06-6.11%
$30.46B
UTHR
United Therapeutics Corporation
$601.25+1.30%
$25.15B
INCY
Incyte Corporation
$120.39+2.95%
$23.69B
INSM
Insmed Incorporated
$112.45+0.83%
$21.18B
EXEL
Exelixis, Inc.
$69.81+5.44%
$16.64B